The events of September 11 raised the world’s awareness of weapons of mass destruction and emerging infectious diseases. The threat of smallpox and anthrax attacks as well as previous SARS and monkey pox outbreaks have underscored the need for the development of new educational initiatives involving biological and chemical threat agents in addition to emerging infectious diseases. In response, our Master of Science in Biohazardous Threat Agents and Emerging Infectious Diseases program aims to broaden the student’s knowledge about prevention, detection and response to chemical, biological and radiological threat agents as well as emerging infectious diseases. Our program focuses on biohazardous agents and emerging infectious diseases facing the world community; whether such threats occur naturally or are purposefully designed. Graduates of our program find opportunities both in biodefense companies as well as with government agencies related to the biohazardous agents and infectious diseases field, while a few may choose to continue their studies in medical school.
Admission to the Master of Science in Biohazardous Threat Agents and Emerging Infectious Diseases program is competitive. Applicants must hold a Bachelors degree with a minimum of a 3.0 GPA. Applicants are required to have taken at least a undergraduate course in biology. The program typically admits 20-25 students a year. The program accepts students in the Fall and Spring, and allows students to choose to be full- and part-students. Visit the Admissions page for more information.
Admissions page for more information.
Students must complete 30 credits of coursework. Students can complete the program in one year attending full-time. Visit our Curriculum page for more information.
Leonard Rosenthal, Ph.D.
Professor & Director, Master’s Program in Biohazardous Threat Agents and EID
Jeff Collmann, Ph.D.
Professor & Director, O’Neill Institute for National and Global Health Law
William Daddio, Ph.D.
Retired Associate Director for Protection/Chief, U.S. Mint Policy, U.S. Mint, Department of the Treasury
Daniel Lucey, M.D., M.P.H.
Former Chief, Infectious Disease Section, Washington Hospital Center
Henry Parker, Ph.D.
Consulting Associate, Centaur Security Solutions, Inc.